APA (7th ed.) Citation

Amarante, I., Faustino, C., Mota, B., Cascais, M., Almeida, J., & Valentim, M. Full recovery over one year of the overlap syndrome scleromyositis to maintenance therapy with mycophenolate mofetil and rituximab, which relapsed within 8 months of discontinuation. SMC MEDIA SRL.

Chicago Style (17th ed.) Citation

Amarante, Inês, Catarina Faustino, Bruna Mota, Mariana Cascais, Jorge Almeida, and Marta Valentim. Full Recovery over One Year of the Overlap Syndrome Scleromyositis to Maintenance Therapy with Mycophenolate Mofetil and Rituximab, Which Relapsed Within 8 Months of Discontinuation. SMC MEDIA SRL.

MLA (9th ed.) Citation

Amarante, Inês, et al. Full Recovery over One Year of the Overlap Syndrome Scleromyositis to Maintenance Therapy with Mycophenolate Mofetil and Rituximab, Which Relapsed Within 8 Months of Discontinuation. SMC MEDIA SRL.